Published in BMJ on January 27, 2001
Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ (2001) 3.44
The discomfort of patient power. BMJ (2002) 3.19
Delivering equitable care: comparing preventive services in Manitoba. Am J Public Health (2003) 1.14
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10
Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ (2001) 4.50
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev (2000) 2.47
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Br J Gen Pract (2000) 2.07
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies. JAMA (1971) 1.31
Immunisation: causes of failure and strategies and tactics for success. BMJ (1989) 4.63
MMR vaccination and autism 1998. BMJ (1998) 2.89
Concerns about immunisation. BMJ (2000) 2.80
Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J (2001) 2.16
Why do parents decide against immunization? The effect of health beliefs and health professionals. Child Care Health Dev (2003) 1.90
Review of neonatal screening programme for phenylketonuria. BMJ (1991) 1.73
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess (2013) 1.31
Clumsiness in children--do they grow out of it? A 10-year follow-up study. Dev Med Child Neurol (1991) 1.29
Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin Perinatol (1999) 1.27
Screening and surveillance for ophthalmic disorders and visual deficits in children in the United Kingdom. Br J Ophthalmol (2001) 1.04
Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age. Vaccine (2001) 0.91
Towards better immunisation rates. Practitioner (1989) 0.88
Safe MMR vaccination despite neomycin allergy. Lancet (1991) 0.87
Autism, inflammatory bowel disease, and MMR vaccine. Lancet (1998) 0.86
Equine multiple acyl-CoA dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the midwestern United States. J Vet Intern Med (2012) 0.86
Gaining children's perspectives: a multiple method approach to explore environmental influences on healthy eating and physical activity. Health Place (2008) 0.84
When is referral of Heaf test positive schoolchildren worth while? More data are needed. BMJ (1997) 0.83
Does primary immunisation status predict MMR uptake? Arch Dis Child (2008) 0.83
Food safety awareness. BMJ (1989) 0.83
Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study. Vaccine (2013) 0.80
Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end. Vaccine (2003) 0.79
Parents' use and views of the national standard Personal Child Health Record: a survey in two primary care trusts. Child Care Health Dev (2007) 0.78
Anhidrotic ectodermal dysplasia: an ENT presentation in infancy. J Laryngol Otol (1988) 0.78
Growth monitoring. Arch Dis Child (2008) 0.76
Tenosynovitis in Lowe syndrome. J Pediatr (1983) 0.76
Vaccination and type 1 diabetes mellitus. BMJ (1999) 0.75
Perhaps it is not time to switch from whole cell to acellular pertussis vaccine. BMJ (2000) 0.75
Health and social care service changes: the potential to increase inequalities. Arch Dis Child (2006) 0.75
National follow up of Haemophilus influenzae meningitis. Arch Dis Child (1993) 0.75
Consider absolute risks in SIDS prevention. Arch Dis Child (2000) 0.75
MMR immunisation. Health professionals should strongly recommend this immunisation. BMJ (2001) 0.75
Vaccines and their real or perceived adverse effects. Studies of adverse effects of vaccination have duty to present full picture. BMJ (1999) 0.75
Antibody response and clinical reactions in children given measles vaccine with immunoglobulin. Br Med J (Clin Res Ed) (1986) 0.75
"They should have them all over the place": a health program for children of illicit drug users. Subst Use Misuse (2000) 0.75
Immunisation. Facts and fiction. Health Visit (1993) 0.75
Achieving immunisation targets: the health visitor's role. Health Visit (1990) 0.75
Social determinants of parent-child interaction in the UK. Child Care Health Dev (2013) 0.75
Mass immunisation: for and against. Nurs Times (1999) 0.75
'Now I understand': consulting parents on chart design and parental information for the UK-WHO child growth charts. Child Care Health Dev (2011) 0.75
Embrace the vital role of immunisation. Nurs Times (2002) 0.75
Childhood immunisation. Paediatr Nurs (1996) 0.75
Epilepsy and the school leaver's medical. Lancet (1978) 0.75
Vaccinations and professional confusion. BMJ (1990) 0.75
Whooping cough immunisation for children with cerebral irritation or damage in the neonatal period. Br Med J (Clin Res Ed) (1986) 0.75